NCT06368115View on ClinicalTrials.gov

A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease: Implementation Phase 2

NAActive, not recruitingINTERVENTIONAL

Enrollment

11,375

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Alzheimer Disease

Interventions

OTHER

Educational Materials

Educational materials on inappropriate prescribing and deprescribing.

Trial Locations (1)

01605

UMass Chan Medical School, Worcester

Sponsors

Collaborators (1)

Carelon Research

All Listed Sponsors

collaborator

National Institute on Aging (NIA)

NIH

collaborator

Harvard Pilgrim Health Care

OTHER

collaborator

Humana Healthcare Research, Inc.

UNKNOWN

collaborator

Carelon Research

OTHER

lead

University of Massachusetts, Worcester

OTHER